Atossa Genetics Inc (ATOS NASDAQ) stock market data APIs
$0.878
-0.02(-2.3%)
as of October 30, 2025
Try our APIs with
free plan!
Atossa Genetics Inc Financial Data Overview
Price chart is built with
Anychart
Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington.
Prev. Close
0.878
Open
0.8568
High
0.9053
Low
0.8549
52 wk Range
0.5526-1.66
Market Cap
114 M
Shares Outstanding
129 M
EPS
-0.07
Beta
1.113
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Atossa Genetics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Atossa Genetics Inc data using free add-ons & libraries
Get Atossa Genetics Inc Fundamental Data
Atossa Genetics Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -29 973 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-12
- EPS/Forecast: -0.06
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Atossa Genetics Inc News
New
New Strong Sell Stocks for Oct. 14th
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: Antero Resources AR is an independent explorer, primarily engaged in the acquisition and development of natural gas, natural...
Notable Friday Option Activity: SPOT, OUST, WOOF
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Spotify Technology SA (Symbol: SPOT), where a total of 10,997 contracts have traded so far,...
Atossa Therapeutics GAAP EPS of -$0.07 misses by $0.01
* Atossa Therapeutics press release [https://seekingalpha.com/pr/20197604-atossa-therapeutics-announces-second-quarter-2025-financial-results-and-provides-a-corporate] (NASDAQ:ATOS [https://seekingal...
European stocks decline after more trade turmoil; U.S. payrolls in focus
Investing.com - European stocks fell Friday as investors digested U.S. President Donald Trump’s fresh levies on imports from dozens of countries as well as more corporate earnings, and the release o...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
